Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — Investor Presentation (February 2017)

28 slides from Navin Fluorine International's investor presentation, February 2017

  1. Slide 1: Navin Fluorine International Limited Investor Presentation

    Navin Fluorine International Limited Investor Presentation February 2017

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  3. Slide 3: Navin Fluorine International Limited

    Navin Fluorine International Limited Building “India’s only plant with high pressure fluorination capabilities with Largest Integrated Specialty cGMP compliance” for CRAMS Business Fluorochemical Company in India Manufacturing plants Over 45 years of expertise strategically located in Handling Fluor

  4. Slide 4: Fluorine Chemistry – A Growing Landscape

    Fluorine Chemistry – A Growing Landscape Global demand for Fluoro-chemicals in 2018 to reach 4.0 Millon MT , with CAGR of 4% per annum Pharmaceuticals Agriculture Electronics Steel Solar / Energy Aluminum White Goods Automotive Glass 4

  5. Slide 5: Evolution of NFIL

    Evolution of NFIL 2015… …2013  Focus on CRAMS & Specialty Chemical Segment to drive growth  CRAMS expansion at Dewas  Commenced CRAMS business in 2011  JV with Piramal Enterprises at Dahej  Acquisition of 51% equity stake in Manchester  Acquired balance 49% stake in MOL Organics Ltd. (MOL) in

  6. Slide 6: Professional Management

    Professional Management Mr. Vishad Mafatlal – Chairman Professional Team …. Mr. Shekhar Khanolkar : Managing Director Chemical Engineer with Masters in Management studies and an alumni of Harvard Business School Spent more than 21 years in the Chemical industry with both Indian & Multinational Chemi

  7. Slide 7: Business Units (BU) - Standalone

    Business Units (BU) - Standalone FY11 – Revenue % FY16 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS – 14% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals –38% Inorganic Fluorides & Refrigerants (Incl. Refrigerants – Refrigerants are CER) –55% 34%

  8. Slide 8: Refrigerants, Inorganic Fluorides: Sustainable and Stable BUs

    Refrigerants Inorganic Fluorides Sustainable and Stable BUs 8

  9. Slide 9: Refrigerants: Growing Demand for Non-Emissive applications

    Refrigerants : Growing Demand for Non-Emissive applications Product User Distribution Export Offering Base Network Outreach  Pioneered  Used in Residential Air  Strong Distribution  Exports to South-East manufacturing of Conditioning Network of dealers in Asia, Middle East, Saudi refrigerant gas

  10. Slide 10: Inorganic Fluorides: Growth from Exports

    Inorganic Fluorides : Growth from Exports Product User Distribution Export Offering Base Network Outreach  Portfolio includes 8-10  Oil & Gas Industry  Developed Strong  Growing exports products network in India  Stainless Steel  From near Zero to ~11%  One of the largest  Presence in all ma

  11. Slide 11: Business Units Performance and Geographic Mix – 9M FY17

    Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs.Crs) 215 113 105 195 194 98 99 94 176 87 154 156 FY12 FY13 FY14 FY15 FY16 9M FY17 FY12 FY13 FY14 FY15 FY16 9M FY17 Exports 7% Geographic Mix – 9M FY17 Exports 30% Domestic Domestic 70% 93% 11 * Standalone Results

  12. Slide 12: Specialty Chemicals, CRAMS: Driving up the Fluorine Value chain

    Specialty Chemicals CRAMS Driving up the “Fluorine Value chain” 12

  13. Slide 13: Specialty Chemicals: Growing product basket

    Specialty Chemicals : Growing product basket Product  Strong Portfolio of value added Specialty Fluoro intermediates Offering  Introduction of novel molecules to expand portfolio  Used by Pharma, Agchem, Petrochem industries User  Focus on deeper penetrating into existing users and Base particip

  14. Slide 14: CRAMS: Scalable Growth through INNOVATION

    CRAMS : Scalable Growth through INNOVATION Strong R&D  Leveraging our proven skills in Developing Contract Fluorination Chemistry Manufacturing Base  State of the art R&D led by qualified and experienced  Setting up manufacturing facility for chemistry teams of PhDs & Post multi-ton batch size, a

  15. Slide 15: Manchester Organics - In Perfect Synergy with CRAMS

    Manchester Organics - In Perfect Synergy with CRAMS  Offer over 60 years of combined  Established in 1996, Manchester Organic chemistry experience to customers Ltd (MOL) has a strong legacy in fluorination and high pressure chemistry  Milligram to multi-kilo research/production  Specialist in fl

  16. Slide 16: Business Units Performance – Specialty Chemicals and CRAMS

    Business Units Performance Specialty Chemicals CRAMS** Revenue (Rs.Crs) 239 87 92 215 178 165 159 156 26 31 14 FY12 FY13 FY14 FY15 FY16 9M FY17 FY13 FY14 FY15 FY16 9M FY17 Domestic 0% Geographic Mix – 9M FY17 Exports 43% Exports 100% Domestic 57% 16 ** CRAMS business generating revenue since FY13 *

  17. Slide 17: CRAMS Business Gains Momentum

    CRAMS Business Gains Momentum Rs. 131 Crs Rs. 80 Crs Rs. 68 Crs Rs. 40 Crs FY13 FY14 FY15 FY16 * CRAMS Consolidated 17

  18. Slide 18: JV with Piramal Enterprises

    JV with Piramal Enterprises  Entered into JV with Piramal Enterprises Ltd  51% - Piramal Enterprises Ltd  49% - Navin Fluorine International Ltd  To develop, manufacture & sell specialty Fluorochemicals for the healthcare segment  Investment outlay of ~Rs. 160 Crs.  Product validation has been

  19. Slide 19: Clients across the Globe

    © Clients across the Globe Ve Responsible Care” =] n Us . ©) CLARIANT™ Cs) Bayer syngenta 5) Bayer CropScience 2 PHARMACEUTICAL xs wr ees Bee —_INDUSTRIESLTD. — LUPIN AUROBINDO to Healthier Life e = Y Dr.REDDY's LIFE. RESEARCH . HOPE + Ne WM ARVIND MAFATLAL GROUP

  20. Slide 20: Key Strengths

    Key Strengths Fluorination Capabilities In-house R&D  Pioneered Manufacturing of  State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat  Over 45 years of experience in  DSIR approved R&D Centre handling Fluorine  Supports in product addition &  Exte

  21. Slide 21: Growth driven by Every Business Unit

    Growth driven by Every Business Unit CRAMS  Business progression from Contract research to contract manufacturing  Manufacturing facility commercially operational Specialty Chemicals  Introduction of new high value added molecules in portfolio  Entry into newer geographies Inorganic Fluorides 

  22. Slide 22: Consistent Dividend Performance

    Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Interim Final Special 210% 185%  Continuous Dividend since 160% 160% last 10 years 150% 150% 150% 140%  Special Dividend of Rs. 60 per share in FY 12  Declared Interim Dividend of Rs. 11.00 per share and a Special

  23. Slide 23: Strategy Begins to Yield Results

    Strategy Begins to Yield Results Operating EBITDA Margin (%) Operating PBT Margin (%) 18% 14% 15% 13% 10% 12% 8% 8% FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 Return on Net Worth (%) Return on Capital Employed (%) 14% 18% 10% 12% 9% 9% 11% 11% FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 23 * Standalone Res

  24. Slide 24: Financial Highlights

    Responsible Care” Financial Highlights

  25. Slide 25: Standalone Profitability Statement - Quarterly

    Standalone Profitability Statement - Quarterly Rs crs. 9M FY17 9M FY16 YoY Q3 FY17 Q3 FY16 YoY Revenue 501 447 12% 154 145 6% Raw Material 206 204 62 70 Employee Expenses 55 46 19 15 Other Expenses 129 116 43 37 Operating EBITDA 111 80 38% 30 23 32% Operating EBITDA Margin 22.1% 18.0% 19.7% 15.8% In

  26. Slide 26: Consolidated Profitability Statement

    Consolidated Profitability Statement Rs. Crs. FY16 FY15 FY14 Revenue 680 592 486 Raw Material 311 289 228 Employee Expenses 81 74 59 Other Expenses 171 156 133 Operating EBITDA 117 72 66 Operating EBITDA Margin 17.3% 12.2% 13.6% Interest Expenses 4 3 6 Depreciation 22 20 22 Operating PBT 91 49 39 Op

  27. Slide 27: Consolidated Balance Sheet

    Consolidated Balance Sheet Rs. Crs. Mar’16 Mar’15 Mar’14 Shareholder’s Fund Share capital 10 10 10 Reserves & Surplus 636 578 546 Minority Interest - 13 9 Non-current liabilities Long term borrowings 48 27 - Deferred Tax Liabilities (net) 37 32 33 Other non-current liabilities 29 28 28 Current liabi

  28. Slide 28: Contact

    Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Mr Jigar Kavaiya / Mr. Sameer Pardikar Chief Financial Offic

Navin Fluorine International — Investor Presentation (February 2017) on 6ix